Pricing Log in Create free account
Saturday 17 October 2026 Export ZBH’s income statement to Excel — free account

Zimmer Biomet Holdings, Inc.

ZBH Healthcare Medical Devices

Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024. In the quarter to June 2026, revenue grew 4.80%, EPS grew 33.8%, free cash flow grew 13.1% and total debt fell 1.23%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five.

95.06 0.68 +0.72%
Market cap
$18.0B
P/E
23.0×
Fwd P/E
17.7×
Dividend yield
1.01%
F-score
6/9
Altman Z
2.38
Beneish M
−2.59
Dividend safety
72/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Zimmer Biomet Holdings, Inc. (ZBH) Price to free cash flow

Alert me on Price to free cash flow

As of 16 October 2026, Zimmer Biomet Holdings, Inc. (ZBH) trades at a price to free cash flow of 17.6×. Over the past ten years it has ranged from 14.5× (December 2018) to 117× (April 2021); the current reading is higher than 11% of that period. That is below the Medical Devices industry median of 23.7× and below the Healthcare sector median of 20.2×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 16.5× (39.70%)
FY2024 27.4× (5.29%)
FY2023 28.9× (5.42%)
FY2022 30.6× 16.34%
FY2021 26.3× (56.97%)
FY2020 61.1× 66.28%
FY2019 36.8× 134.68%
FY2018 15.7× (29.85%)
FY2017 22.3× 22.62%
FY2016 18.2× (59.45%)

Quarterly newest first

Period Price to free cash flow Change
Jun 2026 16.0× (8.73%)
Mar 2026 17.5× 5.83%
Dec 2025 16.5× (14.35%)
Sep 2025 19.3× 10.24%
42 more quarters

Against its own ten years

Low 14.5× High 117×
Ten-year median 26.3×
Current reading's percentile 11

Price to free cash flow against peers

Company Price to free cash flow
SNN Smith & Nephew SNATS, Inc. compare 6.4×
PHG Koninklijke Philips N.V. compare 13.3×
GMED Globus Medical, Inc. compare 14.1×
ZBH Zimmer Biomet Holdings, Inc. 17.6×
GEHC GE HealthCare Technologies Inc. compare 20.0×
STE STERIS plc compare 23.2×
DXCM DexCom, Inc. compare 23.4×
BIO.B Bio-Rad Laboratories, Inc. compare 27.4×
PEN Penumbra, Inc. compare 58.5×
Medical Devices industry median 23.7×
Healthcare sector median 20.2×
Market median 14.2×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on ZBH